Rheonix Obtains $12,600,000 Series A Round

  • Feed Type
  • Date
    4/22/2010
  • Company Name
    Rheonix
  • Mailing Address
    22 Thornwood Drive Ithaca, NY 14850
  • Company Description
    Rheonix, Inc. is exploiting its novel, patented, polymer chip microfluidic technology to introduce products that address some of the hottest issues in global healthcare today: Avian Influenza, HPV, TB, Dengue Fever, AIDS, SARS, bioterrorism, affordable healthcare in developing nations, personalized medicine, and molecular diagnostics, to name a few. Rheonix is not predicated on creating new science; rather its business is bringing to commercial reality the long-promised potential of integrated microfluidic systems. Its unique polymer chip microfluidic technology has produced a wide variety of fluid-handling devices including channels, pumps, reaction vessels, diagnostic chambers, and combinations thereof.
  • Website
    http://www.rheonix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,600,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    With this funding, we will focus on scaling the Rheonix CARD system to demonstrate the full commercial potential of our platform.
  • M&A Terms
  • Venture Investor
    Cayuga Venture Fund
  • Venture Investor
    Onondaga Venture Capital Fund
  • Venture Investor
    Rand Capital
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.